Fibrillin–2 (FBN2) mutations result in the Marfan–like disorder, congenital contractural arachnodactyly

Biochemistry, Genetics and Molecular Biology

• Marfan's Syndrome 100%
• FBN1 66%
• Fibrillin 66%
• Missense Mutation 33%
• Autosomal Dominant Inheritance 33%
• Epidermal Growth Factor 33%
• Cysteine 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Arachnodactyly 100%
• Congenital Disorder 100%
• Marfan Syndrome 42%
• Contracture 14%
• Fibrillin 2 14%
• Scoliosis 14%
• Cysteine 14%
• Epidermal Growth Factor 14%
• Autosomal Dominant Disorder 14%
• Fibrillin 14%

Immunology and Microbiology

• Extracellular Matrix 100%
• Autosomal Dominant Inheritance 50%
• Missense Mutation 50%
• Epidermal Growth Factor 50%
• Cysteine 50%